Nanfei Yang

812 total citations
22 papers, 626 citations indexed

About

Nanfei Yang is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Nanfei Yang has authored 22 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Nanfei Yang's work include Immune cells in cancer (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Nanfei Yang is often cited by papers focused on Immune cells in cancer (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Nanfei Yang collaborates with scholars based in China, United States and Ireland. Nanfei Yang's co-authors include Pingping Shen, Xiujing Feng, Jiajia Chen, Yuxin Shu, Nan Cheng, Dan Weng, Qian Shi, Yahong Huang, Jianguo Ji and Wenlong Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Analytical Biochemistry.

In The Last Decade

Nanfei Yang

20 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nanfei Yang China 12 288 218 128 119 87 22 626
Sven W. Sauer Germany 14 454 1.6× 219 1.0× 88 0.7× 50 0.4× 54 0.6× 17 858
Die Hu China 16 229 0.8× 108 0.5× 74 0.6× 70 0.6× 75 0.9× 41 661
Varvara A. Orekhova Russia 13 337 1.2× 250 1.1× 96 0.8× 32 0.3× 89 1.0× 32 791
Bei Yan China 10 363 1.3× 170 0.8× 121 0.9× 81 0.7× 67 0.8× 13 647
Shijia Wu China 10 482 1.7× 130 0.6× 116 0.9× 80 0.7× 74 0.9× 15 777
Eslam E. Abd El-Fattah Egypt 14 256 0.9× 97 0.4× 72 0.6× 91 0.8× 82 0.9× 18 496
Giovanni Monego Italy 15 312 1.1× 150 0.7× 113 0.9× 111 0.9× 61 0.7× 23 806
Ziyang Cui China 3 266 0.9× 254 1.2× 77 0.6× 42 0.4× 100 1.1× 4 668
Jiao Fan China 15 305 1.1× 127 0.6× 147 1.1× 31 0.3× 57 0.7× 40 638

Countries citing papers authored by Nanfei Yang

Since Specialization
Citations

This map shows the geographic impact of Nanfei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanfei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanfei Yang more than expected).

Fields of papers citing papers by Nanfei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanfei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanfei Yang. The network helps show where Nanfei Yang may publish in the future.

Co-authorship network of co-authors of Nanfei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Nanfei Yang. A scholar is included among the top collaborators of Nanfei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanfei Yang. Nanfei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Nanfei, Qiang Tian, Shuxin Wang, et al.. (2025). FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration. Advanced Science. 12(18). e2408724–e2408724.
3.
Yang, Nanfei, et al.. (2024). An electrochemical immunosensor for sensitive and rapid detection of cystatin C based on Fe3O4/AuNPs-MWCNTs@PDA nanocomposite. Analytical Biochemistry. 696. 115677–115677. 5 indexed citations
4.
Zhang, Zehui, Nanfei Yang, Jia Meng, et al.. (2024). Lipid synthesis, triggered by PPARγ T166 dephosphorylation, sustains reparative function of macrophages during tissue repair. Nature Communications. 15(1). 7269–7269. 22 indexed citations
6.
Ren, Yixian, Xian Wu, Nanfei Yang, et al.. (2024). CDK5-USP30 signaling pathway regulates MAVS-mediated inflammation via suppressing mitophagy in MPTP/MPP+ PD model. Ecotoxicology and Environmental Safety. 279. 116446–116446. 6 indexed citations
7.
Yang, Nanfei, Bing Chen, Yuncheng Bei, et al.. (2023). A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharmaceutica Sinica B. 13(7). 3027–3042. 12 indexed citations
8.
Yang, Nanfei, Qiang Tian, Qiuping Wang, et al.. (2022). Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions. Cell Death and Differentiation. 30(3). 766–778. 12 indexed citations
9.
Zhang, Wenlong, Qing Zhang, Nanfei Yang, et al.. (2022). Crosstalk between IL‐15Rα + tumor‐associated macrophages and breast cancer cells reduces CD8 + T cell recruitment. Cancer Communications. 42(6). 536–557. 39 indexed citations
10.
Wang, Yuxin, Bing Chen, Jingyue Wang, et al.. (2021). Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy. Cell Death and Disease. 12(2). 208–208. 11 indexed citations
11.
Yang, Nanfei, Pei Liu, Ruixuan Zhang, et al.. (2021). Triple signal amplification strategy for the ultrasensitive electrochemical detection of human papillomavirus 16 E6/E7 mRNA. Enzyme and Microbial Technology. 149. 109855–109855. 10 indexed citations
12.
Bei, Yuncheng, Nan Cheng, Ting Chen, et al.. (2020). CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy. Advanced Science. 7(22). 2001417–2001417. 38 indexed citations
13.
Zhao, Fan, Nanfei Yang, Wei Zheng, et al.. (2020). Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells. Experimental Cell Research. 395(2). 112213–112213. 9 indexed citations
14.
Cheng, Nan, Yuncheng Bei, Yue Song, et al.. (2020). B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy. Biochemical Pharmacology. 183. 114298–114298. 54 indexed citations
15.
Yang, Nanfei, Tingzhe Sun, & Pingping Shen. (2020). Deciphering p53 dynamics and cell fate in DNA damage response using mathematical modeling. 1(5). 265–277. 6 indexed citations
16.
Yang, Nanfei, Qing Tang, Zeyang Li, et al.. (2019). Treatment of obesity-related inflammation with a novel synthetic pentacyclic oleanane triterpenoids via modulation of macrophage polarization. EBioMedicine. 45. 473–486. 19 indexed citations
18.
Niu, Zhiyuan, Qian Shi, Wenlong Zhang, et al.. (2017). Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs. Nature Communications. 8(1). 158 indexed citations
19.
Feng, Xiujing, Dan Weng, Feifei Zhou, et al.. (2016). Activation of PPARγ by a Natural Flavonoid Modulator, Apigenin Ameliorates Obesity-Related Inflammation Via Regulation of Macrophage Polarization. EBioMedicine. 9. 61–76. 139 indexed citations
20.
Wu, Wenlei, et al.. (2014). Effect of vitamin C administration on hydrogen peroxide-induced cytotoxicity in periodontal ligament cells. Molecular Medicine Reports. 11(1). 242–248. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026